BioSpace News Archive

CABENUVA offers adults living with HIV a new once-monthly injectable option for maintaining viral suppression

Opportunities for manufacturers in the antiseptic and disinfectant market are projected to primarily arrive from healthcare service providers, estimated to drive sales tantamount to ~US$ 4 Bn by 2020.

Antibacterial drugs have been playing a pivotal role in the prevention of infectious diseases; however, several cases of drug abuse, during the animal breeding process, have led to the development drug resistance.

Assistive technologies demand for visually impaired market is slated to record around 9% CAGR in 2021, with a recent study projecting to surpass an estimation of US$ 7.1 Bn by 2026.

Endoscope is an instrument comprising a light fibre and an image fibre connected to a camera, which captures inside body images at high resolution and sends them to an attached computer for viewing.

Glucocorticoid drugs are synthetic versions of glucocorticoids; steroids that are naturally occurring compounds in the body. These have several functions.

Proprio,today announced a research collaboration with the Department of Neurosurgery at NYU Grossman School of Medicine. Dr. John Golfinos, the Joseph P. Ransohoff Professor and Chair of the Department of Neurosurgery,

The randomized, double-blind, placebo-controlled challenge study is designed to evaluate safety and prophylactic efficacy of MV-012-968 against symptomatic respiratory syncytial virus (RSV)

ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal technologies for treating patients with acute respiratory failure, announced that it has now treated more than 75 COVID-19 patients, and that it is experiencing increasing demand for the Hemolung® Respiratory Assist System as a result of the current pandemic.

Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced the agreement by an accredited healthcare-focused institutional investor to cash exercise certain warrants to purchase up to an aggregate of 10,300,430 shares of common stock having an exercise price of $1.18 issued by the company in December 2020. The shares of common stock issuable upon exercise of the warrants are register